You are here: Industry Insights > Panacea Biotec

News List

Adar Poonawalla sells stake in Panacea Biotec expresspharma
May 19, 2021
He had a 5.15 per cent shareholding in the company and the total value of the transaction was a little over Rs 118 crores.
RDIF and Panacea Biotec partner to produce 100 mn doses of Sputnik V vaccine in India annually expresspharma
April 06, 2021
The Russian Direct Investment Fund (RDIF) and Panacea Biotec announce cooperation to produce 100 million doses per year of Sputnik V.
Panacea Biotec completes Phase I/II study of DengiAll, a tetravalent dengue vaccine candidate expresspharma
September 27, 2020
The company has approached DGCI to seek accelerated review of its data to bring DengiAIl to market quickly.
Panacea Biotec terminates MoU with Refana for COVID-19 vaccine expresspharma
August 24, 2020
The company informed that the termination is due to delays in project timelines and difficulty in moving ahead with the joint venture.
Panacea Biotec aims to make 1-bn doses of COVID-19 vaccine candidate in 2022 expresspharma
July 13, 2020
The company said last month it would partner with US-based Refana Inc to make a potential COVID-19 vaccine, in a collaboration that expects to have over 40 million doses available early next year.
Panacea Biotec and Refana team up for Covid-19 vaccine pharmaceutical-technology
June 15, 2020
India-based Panacea Biotec has partnered with Refana USA for the development, manufacturing and distribution of a Covid-19 vaccine candidate worldwide.
Panacea Biotec and Refana Collaborate for COVID-19 Vaccine contractpharma
June 11, 2020
Partnership will enable global development, manufacturing and distribution of the candidate COVID-19 vaccine.
Panacea Biotec and Refana announce landmark collaboration for COVID-19 vaccine expresspharma
June 10, 2020
Collaboration will enable global development, manufacturing and distribution of the Candidate COVID-19 vaccine.
Panacea Biotec in agreement with Technology Development Board, Govt. of India expressbpd
November 16, 2017
Panacea Biotec’s collaboration with National Institutes of Health (NIH), USA has led to the development of an advanced Dengue Vaccine in India with proven safety in pre-clinical studies.